Emre Gunay
Research Subjects
Research Interests
Emre Gunay has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Haci Hasan Abuoglu
SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL HAYDARPAŞA NUMUNE SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, CERRAHİ TIP BİLİMLERİ BÖLÜMÜ, GENEL CERRAHİ ANABİLİM DALI
2 shared publications - Hakan Uzunoglu
Department of General Surgery, Kartal Dr Lütfi Kırdar City Hospital, 34865 Istanbul, Türkiye
2 shared publications - Bulent Kaya
Department of General Surgery, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey
1 shared publication - Cebrail Akyüz
Department of General Surgery, Haydarpasa Numune Training and Research Hospital, University of Health Sciences, Istanbul 34668, Turkey
1 shared publication - Rıza Adaleti
Sağlık Bilimleri Üniversitesi, Haydarpaşa Numune Eğitim ve Araştırma Hastanesi
1 shared publication - Sevil Ozkan
SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL HAYDARPAŞA NUMUNE SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ
1 shared publication
Latest Publications
- 1 January 2019
- Published by Marmara University in Clinical and Experimental Health Sciences
- Vol. 9 (3) , 261-264
Association Between Onychomycosis and Foot Ulcers in Patients with Diabetes Mellitus
Objective: Diabetes mellitus (DM) is associated with many serious health complications such as diabetic foot ulcer (DFU). Onychomycosis increases the risk for foot disorders and limb amputation in DM patients, and if untreated, can result in tissue degradation and DFU. Therefore, this study aimed to determine the association between the incidences of onychomycosis and DFU. Methods: This study included 40 DM patients with DFU (study group) and 40 DM patients without FU (control group). Samples were obtained from the most affected part of the nail. The deep-nail plaque of the right toe was preferred in patients with normal toenail appearance. In addition, mycological examinations were conducted. Values of p<0.01 were considered as significant. Results: No significant difference was observed between the two groups with respect to age, sex, and hemoglobin A1c levels (p<0.01). However, the incidence of onychomycosis and use of insulin were significantly higher in the study group than in the control group (p<0.01 and p<0.001, respectively). Conclusion: Onychomycosis might be associated with development of FU in patients with DM. By treating onychomycosis early, foot amputation can be prevented.
- 1 January 2019
- Published by Marmara University in Clinical and Experimental Health Sciences
- Vol. 9 (3) , 261-264
Association Between Onychomycosis and Foot Ulcers in Patients with Diabetes Mellitus
Objective: Diabetes mellitus (DM) is associated with many serious health complications such as diabetic foot ulcer (DFU). Onychomycosis increases the risk for foot disorders and limb amputation in DM patients, and if untreated, can result in tissue degradation and DFU. Therefore, this study aimed to determine the association between the incidences of onychomycosis and DFU. Methods: This study included 40 DM patients with DFU (study group) and 40 DM patients without FU (control group). Samples were obtained from the most affected part of the nail. The deep-nail plaque of the right toe was preferred in patients with normal toenail appearance. In addition, mycological examinations were conducted. Values of p<0.01 were considered as significant. Results: No significant difference was observed between the two groups with respect to age, sex, and hemoglobin A1c levels (p<0.01). However, the incidence of onychomycosis and use of insulin were significantly higher in the study group than in the control group (p<0.01 and p<0.001, respectively). Conclusion: Onychomycosis might be associated with development of FU in patients with DM. By treating onychomycosis early, foot amputation can be prevented.
- Open Access
- 1 January 2019
- Published by Celsius Publishing House in Chirurgia
- Vol. 114 (1) , 89-94
Effect of Genetic Factors on the Etiopathogenesis of Thrombosed Hemorrhoidal Disease
The aim of this study is to investigate whether genetic factors known to increase thrombosis risk play a role in the etiopathogenesis of thrombosed hemorrhoidal disease. Methods: Genomic DNA from patients with thrombosed hemorrhoidal disease was analyzed for the presence of factor V Leiden, prothrombin G20210A, methylenetetrahydrofolate reductase C677T, and methylenetetrahydrofolate reductase A1298C mutations. Results: No significant differences were found in the allele frequencies of factor V Leiden, prothrombin G20210A, methylenetetrahydrofolate reductase C677T, and methylenetetrahydrofolate reductase A1298C mutations between patients with thrombosed hemorrhoidal disease and controls (p 0.05). Moreover, there were no significant differences in the genotype (heterozygous and homozygous mutations) of factor V Leiden, prothrombin G20210A, methylenetetrahydrofolate reductase C677T and A1298C mutations between patients with thrombosed hemorrhoidal disease and controls (p 0.05). Conclusions: Our findings indicate that mutations associated with venous thromboembolism do not play a role in the etiopathogenesis of thrombosed hemorrhoidal disease; however, several environmental, mechanical, and hemodynamic factors may contribute to the etiopathogenesis of hemorrhoidal disease.
- 1 January 2019
- Published by Celsius Publishing House in Chirurgia
- Vol. 114 (1) , 89-94
Open AccessEffect of Genetic Factors on the Etiopathogenesis of Thrombosed Hemorrhoidal Disease
The aim of this study is to investigate whether genetic factors known to increase thrombosis risk play a role in the etiopathogenesis of thrombosed hemorrhoidal disease. Methods: Genomic DNA from patients with thrombosed hemorrhoidal disease was analyzed for the presence of factor V Leiden, prothrombin G20210A, methylenetetrahydrofolate reductase C677T, and methylenetetrahydrofolate reductase A1298C mutations. Results: No significant differences were found in the allele frequencies of factor V Leiden, prothrombin G20210A, methylenetetrahydrofolate reductase C677T, and methylenetetrahydrofolate reductase A1298C mutations between patients with thrombosed hemorrhoidal disease and controls (p 0.05). Moreover, there were no significant differences in the genotype (heterozygous and homozygous mutations) of factor V Leiden, prothrombin G20210A, methylenetetrahydrofolate reductase C677T and A1298C mutations between patients with thrombosed hemorrhoidal disease and controls (p 0.05). Conclusions: Our findings indicate that mutations associated with venous thromboembolism do not play a role in the etiopathogenesis of thrombosed hemorrhoidal disease; however, several environmental, mechanical, and hemodynamic factors may contribute to the etiopathogenesis of hemorrhoidal disease.